NanoSphere Health Sciences Inc.
NSHS.CN
Get informed when a big investor buys or sells
+ FollowMarket Cap$205.5K
Close$
$-0.01
137.5% downside
Current Fair Value
137.5% downsideOvervalued by 137.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $205,504.00 |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.02 |
| Outstanding Shares | 10,275,205 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 9.35 |
|---|---|
| PEG | 4.68 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NanoSphere Health Sciences Inc.
3 employees
CEO: Michael Alexander Iverson NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, concentrating on the provision of biologically active compounds throughout both the United States and Canada. Its principal offering is the NanoSphere Deliver S...